Delivery Order SPE2DB22D1200-SPE2DB24FN1CF
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The order is for the delivery of Vyvanse 40 mg capsules, a brand name medication, worth $1,215.05. The delivery order has a completion date of February 15, 2024 and was awarded on February 14, 2024. This delivery order is placed under an Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of 4,563,606,240 units of Vyvanse 40 mg capsules, with a potential value of $3,138.50. The contract completion date is February 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and...
- This firm fixed price delivery order, valued at $16,404.02, was awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical to supply 4,564,042,330 units of the prescription medication Vyvanse 40 mg capsules. The delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen that has a potential value of up to $999,999,999.00 and runs through December 31, 2025. This IDC serves as the primary contract vehicle for...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, to supply 4,564,001,383 units of the drug Vyvanse 40 mg capsules. The $1,724.00 order has a completion date of March 19, 2024 and does not utilize a set-aside. AmerisourceBergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025 to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, the prime contractor. The order, valued at $5,984.69, is for the delivery of 4,564,095,571 units of the pharmaceutical product Vyvanse 40 mg capsules. The contract has a ceiling value of $5,984.69 and a performance period ending on March 28, 2024. This order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp,...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Vyvanse 40 mg capsules, a brand name pharmaceutical product, with a ceiling value of $1,054.38 and a period of performance through April 5, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 40 mg capsules. The delivery order, valued at $1,309.46, is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a total potential value of up to $999,999,999 through December 2025. The IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 100 units of the drug Vyvanse 60 mg capsules, with a completion date of February 16, 2024 and a potential value of $1,724.00. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 100 units of the prescription drug Vyvanse 40 mg capsules. The order has a potential value of $1,549.15 and a completion date of January 25, 2024. As a prime contractor, Amerisourcebergen Drug Corp has previously provided a range of pharmaceutical products and medical supplies to support DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor. The $1,641.92 contract is for the supply of 4,565,712,501 units of the prescription drug Vyvanse 40 mg capsule. The order has a firm fixed price and an ultimate completion date of September 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB24FN1CFDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The order is for 100 units of the pharmaceutical product Vyvanse 40 mg capsule, with a completion date of March 4, 2024 and a potential value of $2,747.98. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this particular delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 3/1/24 |